QuickView for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=7F4E500892A79E27C46CA5D54B2ABAC8;jsessionid=DFF780B5C620BEFC9E0FD3E08D27AAF9;jsessionid=6D92ED2E4CABDB929802359ED74AD1D5;jsessionid=ADB879AA47D4AB9122138EC5BE6A5E2E;jsessionid=F868498BFC9989F3875B9AA9FE975AEB;jsessionid=16E5AA97A6BB75DD2A20D2AC12EC3771 (gene)

1. AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistan…
2. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
3. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Mat…
4. A chemical compound inhibiting the Aha1-Hsp90 chaperone complex.
5. Cooperative Nucleotide Binding in Hsp90 and Its Regulation by Aha1.

There were no clinical trials for AHSA1;jsessionid=BB00502B7E785F08F8DBB588B0A0C812;jsessionid=8CAE4D2F6D2ADAA7000690C3A4BABDF2;jsessionid=59527D2BB9ADB40D0FF86D690D2CAA77;jsessionid=7F4E500892A79E27C46CA5D54B2ABAC8;jsessionid=DFF780B5C620BEFC9E0FD3E08D27AAF9;jsessionid=6D92ED2E4CABDB929802359ED74AD1D5;jsessionid=ADB879AA47D4AB9122138EC5BE6A5E2E;jsessionid=F868498BFC9989F3875B9AA9FE975AEB;jsessionid=16E5AA97A6BB75DD2A20D2AC12EC3771